Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BIOC

Biocept (BIOC) Stock Price, News & Analysis

Biocept logo

About Biocept Stock (NASDAQ:BIOC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.43
$1.67
52-Week Range
N/A
Volume
751,400 shs
Average Volume
764,067 shs
Market Capitalization
$1.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BIOC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biocept and its competitors with MarketBeat's FREE daily newsletter.

BIOC Stock News Headlines

A $674B Industry Missed the Bigger Picture
TV video streaming exploded into a $674.25B market in 2024—driven by the hours we spend lost in entertainment. But there’s a much bigger habit consuming our time, with value that’s waiting to be unlocked. Smartphone screen time. We spend over 30 hours a week glued to our phones. Mode Mobile is pioneering ways to turn those hours into real income. Their EarnPhone unlocks 19 revenue streams from everyday phone use, helping users earn over $325M so far. Deloitte crowned them North America’s fastest-growing software company in 2023 after their revenue soared 32,481% from 2019-2022. But this industry is still in its infancy, and you can invest in the company that’s at the forefront of unlocking its value.
See More Headlines

BIOC Stock Analysis - Frequently Asked Questions

Biocept, Inc. (NASDAQ:BIOC) released its earnings results on Monday, November, 15th. The medical research company reported $0.90 EPS for the quarter, missing analysts' consensus estimates of $2.70 by $1.80. The medical research company had revenue of $17.47 million for the quarter, compared to analyst estimates of $16.87 million.

Biocept shares reverse split on Wednesday, May 17th 2023.The 1-30 reverse split was announced on Wednesday, May 17th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biocept investors own include Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), T2 Biosystems (TTOO), VBI Vaccines (VBIV), Vaxart (VXRT), NIO (NIO) and iBio (IBIO).

Company Calendar

Last Earnings
11/15/2021
Today
7/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOC
CIK
1044378
Employees
50
Year Founded
1993

Profitability

EPS (Trailing Twelve Months)
($58.4549)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.09 million
Net Margins
N/A
Pretax Margin
-564.02%
Return on Equity
-468.87%
Return on Assets
-118.41%

Debt

Debt-to-Equity Ratio
2.88
Current Ratio
1.81
Quick Ratio
1.70

Sales & Book Value

Annual Sales
$25.86 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$15.60 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,630,000
Free Float
2,584,000
Market Cap
$1.14 million
Optionable
Not Optionable
Beta
0.69

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:BIOC) was last updated on 7/29/2025 by MarketBeat.com Staff
From Our Partners